Investigating what happened to Sodium Dichloroacetate DCA (NaDCA) is a form of neutralized dichloroacetic acid (dichloroacetate or DCA), the non-toxic cancer cure discovered by a large Canadian University in 2007. The short answer is they have had to raise the money for clinical trials from the public, and that DCA worked the same in humans as it did in the lab!
Background
In 2007 it was discovered that the drug DCA (dichloroacetate sodium) induced the death of human breast, lung and brain cancer cells that were implanted into rats, while being non-toxic to healthy cells. This research was published in Cancer Cell, January 2007. DCA has been found to kill cancer cells by a newly discovered mechanism that appears to be common to several types of cancer. DCA is a synthetic drug, but it is a very simple compound similar to a chemical combination of salt and vinegar. It works by turning on the natural cell suicide system (called apoptosis) which is suppressed in cancerous cells, thus allowing them to die on their own. DCA does not poison the cells like cytotoxic chemotherapy drugs. DCA also interferes with the cancer cell’s use of glucose, starving the cell of energy. At the same time, it does not starve healthy cells in the body of glucose.
DCA cancer research continues over a decade after the original publication in Cancer Cell. The latest research shows that DCA also kills many types of cancer cells, and can boost the cancer-killing effects of radiation. The first formal human cancer research using DCA was published in May 2010. It confirmed that DCA is an effective anti-cancer drug for treating glioblastoma patients (Metabolic Modulation of Glioblastoma with Dichloroacetate, Science Transitional Medicine, Vol 2, Issue 31). MEDLINE is the largest medical database in the world, and contains information on published DCA research. This database can be searched free of charge for those interested in reading DCA Research, or the summaries of the DCA publications.